Literature DB >> 18768108

Identification of two novel arylsulfatase A mutations with a polymorphism as a cause of metachromatic leukodystrophy.

Evren Onder1, Incilay Sinici, F Müjgan Sönmez, Meral Topçu, H Asuman Ozkara.   

Abstract

OBJECTIVE: Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulfatase A or saposin B. Enzyme deficiency leads to the accumulation of sulfatide, which results in severe demyelination.
METHODS: In this study, clinically suspected patients were diagnosed as metachromatic leukodystrophy by enzyme analysis using p-nitrocathecol sulfate as substrate. Eight exons and flanking regions of arylsulfatase A gene of patients were amplified by polymerase chain reaction and then subjected to single stranded conformational polymorphism analysis. Polymerase chain reaction products of suspicious exons in single stranded conformational polymorphism were purified from agarose gel and sequenced.
RESULTS: DNA sequencing revealed two novel disease-causing missense mutations: the first one is 1568G-->A, 307Glu-->Lys in exon 5 which is together with a 2161C-->T, 391Thr-->Ser polymorphism in exon 7; and the second one is 1603G-->T, 318Trp-->Cys in exon 5. DISCUSSION: These two mutations are in highly conserved structural elements region of the arylsulfatase A protein. Thus, missense mutations 307Glu-->Lys in exon 5 and 318Trp-->Lys in exon 5 probably change the active site conformation by disrupting the sixth alpha helix and the twelfth beta-sheet structure of the arylsulfatase A protein, respectively, and cause deficiency in enzyme activity. This study provides the molecular basis for understanding the mechanism underlying metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768108     DOI: 10.1179/016164108X323762

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

1.  Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy.

Authors:  Samuel Groeschel; Christine í Dali; Philipp Clas; Judith Böhringer; Morten Duno; Christian Krarup; Christiane Kehrer; Marko Wilke; Ingeborg Krägeloh-Mann
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

2.  Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations.

Authors:  Adem Özkan; Hatice Asuman Özkara
Journal:  Intractable Rare Dis Res       Date:  2016-11

3.  Brain MRI and biological diagnosis in five Tunisians MLD patients.

Authors:  Ilhem Barboura; Samir Hadded; Saber Chebel; Rachida Ben Mansour; Hinda Chahed; Mohamed-Néji Gueddiche; Mahbouba Frih-Ayed; Salima Ferchichi; Abdelhédi Miled
Journal:  Diagn Pathol       Date:  2012-01-28       Impact factor: 2.644

4.  Identification of a missense ARSA mutation in metachromatic leukodystrophy and its potential pathogenic mechanism.

Authors:  Liyuan Guo; Bo Jin; Yidan Zhang; Jing Wang
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.